Summary
Definition
History and exam
Key diagnostic factors
- congestive heart failure, pneumonia, and malignancy
- dyspnea
- dullness to percussion
Other diagnostic factors
- pleuritic chest pain
- cough
- absent or decreased breath sounds
- decreased or absent tactile fremitus
Risk factors
- congestive heart failure
- pneumonia
- malignancy
- pulmonary embolism
- recent coronary artery bypass graft surgery
- recent myocardial infarction
- occupational lung disease
- rheumatoid arthritis
- systemic lupus erythematosus
- renal failure
- drug-induced pleural effusion
- recent ovarian stimulation treatment
- trauma
Diagnostic tests
1st tests to order
- posteroanterior and lateral chest x-ray
- pleural ultrasound
- LDH and protein in pleural fluid and serum
- red blood cell count in pleural fluid
- WBC count and differential of pleural fluid
- cytology of pleural fluid
- culture of pleural fluid
- pH of pleural fluid
- glucose in pleural fluid
- protein gradient
- CBC
- C-reactive protein (CRP)
- blood culture
- sputum Gram stain and culture
- N-terminal pro-brain natriuretic peptide (NT-pro-BNP) in pleural fluid and serum
Tests to consider
- pleural fluid cholesterol level
- thoracic CT scan
- thoracic MRI
- amylase in pleural fluid
- adenosine deaminase (ADA) level in pleural fluid
- lipid analysis of pleural fluid
- antinuclear antibody (ANA) analysis of pleural fluid
- thoracoscopy
- bronchoscopy
- pleural biopsy
- interferon-gamma in pleural fluid and real-time polymerase chain reaction of pleural fluid
- procalcitonin
Emerging tests
- tumor markers
Treatment algorithm
congestive heart failure
infective
malignant: poor performance status or limited lifespan (Karnofsky score ≤30% or ECOG score of ≥2)
malignant: good performance status (Karnofsky score >30% or ECOG score of 0 or 1)
persistent empyema despite chest tube
recurrent symptomatic malignant effusions
recurrent benign effusion
Contributors
Authors
Orhan Orhan, MBBS, BSc, FRCP, SFHEA, MSc
Consultant Respiratory Physician
Chelsea and Westminster Hospital NHS Foundation Trust
London
UK
Disclosures
OO declares that he has no competing interests.
Acknowledgements
Dr Orhan Orhan would like to gratefully acknowledge Drs Clare Ross, Philip W. Ind, Anob M. Chakrabarti, Richard Light, Amber Degryse, Rachel J. Davies, and Peter M. George, previous contributors to this topic.
Disclosures
RL received speaking fees provided by Cardinal Health; owned stock in Denver Biomaterials until it was purchased by Cardinal Health; received fees for consulting from Denver Biomaterials; and is an author of references cited in this topic. CR, PWI, AMC, AD, RJD, and PMG declare that they have no competing interests.
Peer reviewers
Y.C. Gary Lee, MBChB, PhD, FCCP, FRACP
Consultant Chest Physician and Senior Lecturer
Oxford Centre for Respiratory Medicine and University of Oxford Churchill Hospital
Oxford
UK
Disclosures
YCGL declares that he has no competing interests.
Clare Hooper, MBBS
Pleural Research Registrar
North Bristol Lung Centre
Southmead Hospital
Westbury on Trym
Bristol
UK
Disclosures
CH declares that she has no competing interests.
Benjamin DeMarco, MD
Assistant Professor of Medicine
Division of Pulmonary and Critical Care Medicine
University of North Carolina School of Medicine
Chapel Hill
NC
Disclosures
BD declares that he has no competing interests.
Peer reviewer acknowledgements
BMJ Best Practice topics are updated on a rolling basis in line with developments in evidence and guidance. The peer reviewers listed here have reviewed the content at least once during the history of the topic.
Disclosures
Peer reviewer affiliations and disclosures pertain to the time of the review.
References
Key articles
Feller-Kopman D, Light R. Pleural Disease. N Engl J Med. 2018 Feb 22;378(8):740-751.
Roberts ME, Rahman NM, Maskell NA, et al. British Thoracic Society Guideline for pleural disease. Thorax. 2023 Jul;78(suppl 3):s1-42.Full text
Sundaralingam A, Grabczak EM, Burra P, et al. ERS statement on benign pleural effusions in adults. Eur Respir J. 2024 Dec;64(6):2302307.Full text Abstract
Expert Panel on Thoracic Imaging, Morris MF, Henry TS, et al. ACR Appropriateness Criteria® workup of pleural effusion or pleural Disease. J Am Coll Radiol. 2024 Jun;21(6):S343-52. Abstract
Bibby AC, Dorn P, Psallidas I, et al. ERS/EACTS statement on the management of malignant pleural effusions. Eur Respir J. 2018 Jul;52(1):1800349.Full text Abstract
Feller-Kopman DJ, Reddy CB, DeCamp MM, et al. Management of malignant pleural effusions. An official ATS/STS/STR clinical practice guideline. Am J Respir Crit Care Med. 2018 Oct 1;198(7):839-49.Full text Abstract
Reference articles
A full list of sources referenced in this topic is available to users with access to all of BMJ Best Practice.

Differentials
- Pleural thickening
- Pulmonary collapse and consolidation
- Elevated hemidiaphragm
More DifferentialsGuidelines
- ACR appropriateness criteria: chylothorax treatment planning
- ACR appropriateness criteria: chronic dyspnea-noncardiovascular origin
More GuidelinesPatient information
Pleural effusion
Chest drain insertion
More Patient informationVideos
Pleural aspiration animated demonstration
Insertion of intercostal drain, Seldinger technique: animated demonstration
More videosLog in or subscribe to access all of BMJ Best Practice
Use of this content is subject to our disclaimer